Analyst firms · H.C. Wainwright · CRTX

H.C. Wainwright CRTX price target and rating history

Cortexyme Inc. (CRTX) · Health Care

H.C. Wainwright rates Cortexyme Inc. (CRTX) Buy with a $15 price target, as of its latest action on Mar 9, 2022. It has published 3 rating actions on CRTX since August 2021, including 0 upgrades and 0 downgrades.

Current rating
Buy
Price target
$15
Median target, all firms
Too few
Actions on CRTX
3

H.C. Wainwright price target on CRTX

$200$108$1520222023202420252026
H.C. Wainwright price target on CRTX, each point a stated target, August 2021 to March 2022.

Every H.C. Wainwright rating on CRTX

Questions about H.C. Wainwright and CRTX

What is H.C. Wainwright's price target for CRTX?
H.C. Wainwright's latest stated price target for Cortexyme Inc. (CRTX) is $15, from its action on Mar 9, 2022.
What is H.C. Wainwright's rating on CRTX?
H.C. Wainwright rates CRTX Buy, a bullish rating, as of Mar 9, 2022.
When did H.C. Wainwright last change its view on CRTX?
On Mar 9, 2022, H.C. Wainwright cuts its price target to $15 from $30, keeps Buy.

More CRTX rating histories

All H.C. Wainwright ratingsCRTX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.